Trimethoprim Sulfamethoxazole (TMP-SMX) represents the first-line treatment to HIV-seropositive patients for prophylaxis or treatment of pneumonia for Pneumocistis Carini, but is commonly discontinued because of hypersensitivity reactions. Different studies have tried long and short desensitization schemes, ...
sinusitisurinary tract infectiontrimethoprim-sulfamethoxazoleHIV/AIDSTo determine the association between trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis for ... SR Tabet,MR Krone,TM Hooton,... - 《International Journal of Std & Aids》 被引量: 12发表: 1997年 Acknowledgments: Antimicrobial treatment...
TMP/SMX is first-line therapy for PCP in HIV-positive individuals, despite a high frequency of toxic effects in these patients. In addition to the ... Porras,M. - 《Annals of Pharmacotherapy》 被引量: 484发表: 1998年 Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transpl...
EFFECT OF TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS ON FAECAL CARRIAGE RATES OF RESISTANT ISOLATES OF ESCHERICHIA COLI IN HIV-INFECTED ADULT PATIENTS IN LAGOS Background:The daily use of Trimethoprim-Sulfamethoxazole (TMP-SMX) prophylaxis reduces morbidity and mortality among patients infected with Human Immu...